Join our email list to stay up to date on the latest Amyloidosis news.

In this ARC Talks Webinar for patients and caregivers, Professor Julian Gillmore, the Head and Research Lead of the National Amyloidosis Centre in London,  will describe the role of gene editing in hereditary diseases like hATTR, and share the early results of Intellia’s CRISPR trial. Intellia’s Head of Development for In Vivo programs, Dr. Liron Walsh, will join Professor Gillmore for a question and answer session.

*

*

*

*